Novavax

This large, final-stage study tested a new combination vaccine that aims to protect against both COVID-19 and the flu with a single shot. About 9,300 adults aged 65 and older took part, receiving either the combo vaccine or a standard high-dose flu vaccine. Researchers checked ho…

This study tested Novavax's COVID-19 vaccine in 3,600 children aged 6 months to 12 years. The goal was to see if the vaccine is safe and triggers a strong immune response. Children received two doses 21 days apart, with some getting a placebo. The trial is complete, and results w…

This study tested whether three different manufacturing batches (lots) of Novavax's COVID-19 vaccine produce the same immune response and safety in adults. About 900 healthy adults aged 18 to 49 who had already been vaccinated received one of the three lots. The results help ensu…

This completed study looked at how often healthcare workers and first responders experienced short-term side effects (like fever or sore arm) after getting either the updated Novavax or Pfizer COVID-19 vaccine. About 660 adults who had at least one prior COVID-19 shot took part. …